Beta2-adrenoceptor regulation of the K+ channel iKCa1 in human mast cells
Related Experiment Video
Updated: Aug 18, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
S Mark Duffy1, Glenn Cruse, Wendy J Lawley
1Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Insights
Beta2-adrenoceptor agonists like salbutamol close the iKCa1 channel in human mast cells, reducing their activation. This occurs via a G protein-coupled receptor mechanism, explaining the stabilizing effect of these common asthma medications.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Human mast cells possess the iKCa1 channel, crucial for IgE-dependent activation, Ca2+ influx, and degranulation.
- Beta2-adrenoceptor agonists, such as salbutamol, are known to attenuate mast cell activation, a process previously attributed to cyclic AMP.
- The precise molecular mechanism underlying beta2-agonist effects on mast cells remained unclear.
Purpose of the Study:
- To investigate the effect of salbutamol on the iKCa1 channel in human mast cells.
- To elucidate the signaling pathway involved in beta2-adrenergic regulation of iKCa1.
- To provide a molecular mechanism for the mast cell stabilizing effects of beta2-agonists.
Main Methods:
- Electrophysiological recordings of iKCa1 currents in human lung and peripheral blood-derived mast cells.
- Pharmacological manipulation using salbutamol, 1-EBIO, ICI 118551, and modulators of cAMP, Galphai, and Galphas.
- Assessment of mast cell activation markers following anti-IgE stimulation.
Main Results:
- Salbutamol was found to inhibit iKCa1 currents in activated human mast cells.
- The beta2-adrenergic antagonist ICI 118551 reversed salbutamol's effect and also opened iKCa1 in quiescent cells, indicating constitutive beta2-receptor signaling.
- Signaling involved a membrane-delimited pathway mediated by Galphas, independent of intracellular cAMP levels.
Conclusions:
- Gating of the iKCa1 channel in human mast cells is directly regulated by G protein-coupled receptors, specifically the beta2-adrenoceptor.
- This study defines a novel mechanism for the mast cell stabilizing effect of beta2-agonists.
- Constitutive beta2-receptor activity influences the threshold for human mast cell activation via iKCa1 regulation.
Abstract:
Human mast cells express the intermediate conductance Ca2+-activated K+ channel iKCa1, which opens following IgE-dependent activation. This results in cell membrane hyperpolarization and potentiation of both Ca2+ influx and degranulation. Mast cell activation is attenuated following exposure to beta2-adrenoceptor agonists such as salbutamol, an effect postulated to operate via intracellular cyclic AMP. In this study, we show that salbutamol closes iKCa1 in mast cells derived from human lung and peripheral blood. Salbutamol (1-10 microM) inhibited iKCa1 currents following activation with both anti-IgE and the iKCa1 opener 1-EBIO, and was reversed by removing salbutamol or by the addition of the selective beta2-adrenoceptor antagonist and inverse agonist ICI 118551. Interestingly, ICI 118551 consistently opened iKCa1 in quiescent cells, suggesting that constitutive beta2-receptor signaling suppresses channel activity. Manipulation of intracellular cAMP, Galphai, and Galphas demonstrates that the beta2-adrenergic effects are consistent with a membrane-delimited mechanism involving Galphas. This is the first demonstration that gating of the iKCa1 channel is regulated by a G protein-coupled receptor and provides a clearly defined mechanism for the mast cell "stabilizing" effect of beta2-agonists. Furthermore, the degree of constitutive beta2-receptor "tone" may control the threshold for human mast cell activation through the regulation of iKCa1.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antihypertensive Drugs: Action of Calcium Channel Blockers
cAMP-dependent Protein Kinase Pathways

